Bridge to Life Ltd.: Funding, Investors & Team (Sep 2026)
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new preservation solutions and technologies to provide the highest quality of service to organ procurement organizations and transplant centers. The U.S. based company, headquartered in Northbrook, Illinois, is a leading supplier of preservation solutions worldwide with a focus on innovation in organ preservation and machine perfusion. Through a strong focus on collaboration with surgeons and transplant professionals, it continues to explore emerging science and preservation technologies.
Bridge to Life Ltd. has raised $166M across 2 funding rounds on record, the most recent a Series C of $110M announced in Aug 2026.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Bridge to Life Ltd. Company Profile and Key Stats
Latest funding round on record: Aug 2026.
Bridge to Life Ltd. Funding Rounds
Bridge to Life Ltd. raised $56.0M in an undisclosed round announced in Aug 2021.
5 years later, a Series C of $110M was announced in Aug 2026.
Bridge to Life Ltd. Investors
Bridge to Life Ltd. Founders and Leadership Team
Contact details for the Bridge to Life Ltd. team: 1 of 2 have an email address on file, 2 have a LinkedIn profile.
Start 14-day free trial →Bridge to Life Ltd. Funding Compared to Other Biotechnology Startups
Bridge to Life Ltd.'s latest round of $110M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Bridge to Life Ltd. in Biotechnology and Northbrook
Companies Similar to Bridge to Life Ltd.
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
Aureka Biotechnologies is a pioneering biotech firm dedicated to democratizing the pharmaceutical sector in…
Bridge to Life Ltd. Funding FAQs
What does Bridge to Life Ltd. do?
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new preservation solutions and technologies to provide the highest quality of service to organ procurement organizations and transplant centers. The U.S. based company, headquartered in Northbrook, Illinois, is a leading supplier of preservation solutions worldwide with a focus on innovation in organ preservation and machine perfusion. Through a strong focus on collaboration with surgeons and transplant professionals, it continues to explore emerging science and preservation technologies.
How much funding has Bridge to Life Ltd. raised?
Bridge to Life Ltd. has raised $166M across 2 rounds on record. The most recent is a Series C of $110M announced in Aug 2026.
When did Bridge to Life Ltd. last raise funding?
Bridge to Life Ltd.'s most recent funding round on record is a Series C of $110M, announced in Aug 2026.
Who has invested in Bridge to Life Ltd.?
Investors on record for Bridge to Life Ltd. include Perceptive Advisors, Soleus Capital, Lauxera Capital Partners, Peter Maag.
Who is the CEO of Bridge to Life Ltd.?
Don Webber is listed as CEO at Bridge to Life Ltd..
Where is Bridge to Life Ltd. headquartered?
Bridge to Life Ltd. is based in Northbrook, Illinois, United States.
How many employees does Bridge to Life Ltd. have?
Bridge to Life Ltd. is in the 101-250 employee band.
When was Bridge to Life Ltd. founded?
Bridge to Life Ltd. was founded in 2005.
How does Bridge to Life Ltd.'s funding compare to other Biotechnology startups?
Bridge to Life Ltd.'s latest round of $110M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Bridge to Life Ltd. Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Bridge to Life Ltd. is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.